Tiotropium HandiHaler(®) and Respimat(®) in COPD: a pooled safety analysis

INTRODUCTION: Tiotropium is prescribed for the treatment of chronic obstructive pulmonary disease (COPD) and delivered via HandiHaler(®) (18 μg once daily) or Respimat(®) Soft Mist™ inhaler (5 μg once daily). The recent TIOtropium Safety and Performance In Respimat(®) (TIOSPIR™) study demonstrated t...

Descripción completa

Detalles Bibliográficos
Autores principales: Halpin, David MG, Dahl, Ronald, Hallmann, Christoph, Mueller, Achim, Tashkin, Donald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4332287/
https://www.ncbi.nlm.nih.gov/pubmed/25709423
http://dx.doi.org/10.2147/COPD.S75146

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4332287/
https://www.ncbi.nlm.nih.gov/pubmed/25709423
http://dx.doi.org/10.2147/COPD.S75146

Ejemplares similares